-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Kalaris Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2019 to Q1 2025.
- Kalaris Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$7.44M, a 64.6% decline year-over-year.
- Kalaris Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$67.7M, a 45.6% increase from 2023.
- Kalaris Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$124M, a 12.4% increase from 2022.
- Kalaris Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$142M, a 33.6% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)